Paratek Pharmaceuticals Stock Price. Everything You Need To Know About The Paratek Pharmaceuticals Stock!
Paratek Pharmaceuticals, Inc. is a leading biopharmaceutical company headquartered in Boston, Massachusetts, with a team of 268 full-time employees. Since its IPO on May 10, 2006, the company has been dedicated to developing and commercializing life-saving therapies based on tetracycline chemistry, with a focus on treating life-threatening diseases and other public health threats for civilian, government, and military use.
Paratek Pharmaceuticals, Inc.’s commercial product NUZYRA (omadacycline) is a once-daily oral and intravenous antibiotic that is designed to treat adult patients with community-acquired bacterial pneumonia (CABP) and acute skin and skin structure infections (ABSSSI) caused by susceptible pathogens. Meanwhile, its other commercial product, SEYSARA (sarecycline), is a once-daily oral therapy that specifically targets moderate to severe acne vulgaris. As a narrow-spectrum tetracycline, SEYSARA is optimized for dermatological use.
Paratek Pharmaceuticals, Inc. markets omadacycline in the United States as an empiric monotherapy for the indications of ABSSSI and CABP in patients who have both a known or suspected resistant pathogen and at least one significant comorbidity. By providing innovative therapies for serious health conditions, Paratek Pharmaceuticals, Inc. continues to demonstrate its commitment to improving patient outcomes.
Staying informed about the company’s latest developments, such as its stock price today, can provide valuable insights for investors and healthcare professionals alike. For those interested in investing in the pharmaceutical industry, researching Paratek Pharmaceuticals, Inc.’s innovative technologies and commercial products can provide a foundation for making informed decisions.
Paratek Pharmaceuticals Stock Price. Everything You Need To Know About The Paratek Pharmaceuticals Stock! performance
- Employees 268
- Company HQ Boston
- Website http://paratekpharma.com/
- Asset Type
- Market Capitalization 0
- Earnings Per Share
- Dividends Per Share
- Dividend Date
- Quarterly Earnings Growth
Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in the stock market? Look no further than Paratek Pharmaceuticals. As a content marketing expert at Zorion, I can guide you through the process of investing in this promising stock. Paratek Pharmaceuticals, a renowned pharmaceutical company, offers a unique investment opportunity to potential shareholders. With Zorion’s investment insights and recommendations, you can make well-informed decisions about investing in Paratek Pharmaceuticals. Our platform also provides access to resources and educational materials, allowing you to expand your investment knowledge. Take the first step towards financial growth and invest in Paratek Pharmaceuticals with Zorion today!
